The Mario Negri Institute for Pharmacological Research, a PERMIT consortium member, has published an article in its online magazine on personalised medicine. It provides an overview, in lay terms of the basis of personalised medicine, its fields of application, its current challenges, its costs and the ethical questions it raises. The article also highlights European initiatives on personalised medicine such as the ICPerMed and the PERMIT Project and provides outlooks on the future of personalised medicine. Read the full article here (article in Italian).
@EatrisEric
Aug 25th
EATRIS is a partner of the #PERMITproject, which has had another article published in PLOSCompBiol. The piece covers 10 tips for #biomarker discovery & validation analyses using #MachineLearning". Congratulations to all involved.
👉Read the article herdoi.org/10.1371/journa…c5P https://t.co/sbStQ2seON
@ICPerMed
Aug 23rd
📢News from t#ICPerMedfamilyily
👏New publication fro#PERMITprojectroject
📰"Ten quick tips for biomarker discovery and validation analyses using machine lejournals.plos.org/ploscompbiol/a…otwitter.com/ECRIN_ERIC/sta…o/6wfK70z3j8
@ECRIN_ERIC
Aug 22nd
New Publication from the #PERMITproject:
10 Tips for biomarker discovery and validation analyses using machine learning.
Broadly applicable tips to address some of the most common pitfalls and limitations for biomarker signature development.
permit-eu.org/publications https://t.co/CBZ43ck7yI
